| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate |
2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_333150abb28d231c8be087577981aace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3d4b2e1067dded2452dd7052df7d10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49359d5758e4125e46dd1d4a113d74e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a13e8d138e16c7d0b3da6595f7e375 |
| publicationDate |
2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190117072-A |
| titleOfInvention |
Controlled Release Pharmaceutical Composition comprising Mirabegron |
| abstract |
The present invention provides a controlled release pharmaceutical composition comprising a mirabegron or a pharmaceutically acceptable salt thereof, and a sustained-release agent, wherein the sustained-release agent uses a polymer together with a gum to form a hydrogel. , To controlled release pharmaceutical compositions and methods of making the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210112240-A |
| priorityDate |
2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |